Industry taskforces

Health Systems Taskforce

Letter of intent

At His Royal Highness The Prince of Wales invitation, leaders from across the healthcare system have come together to form a Health Systems Taskforce as part of the Sustainable Markets Initiative. The Taskforce will work together to accelerate the delivery of net zero, sustainable healthcare to improve individual, societal and planetary health.

The Health Systems Taskforce is championed by AstraZeneca’s Chief Executive Officer, Pascal Soriot, and includes CEO or equivalent-level representation from GSK, Merck, Roche, Samsung Biologics, Sanofi, Novo Nordisk, the World Health Organization, UNICEF, NHS England, the Sustainable Healthcare Coalition, the Health and Global Policy Institute of Japan, the Karolinska Institutet and the University of Pavia. The group has been formally launched at COP26 to seize upon the momentum created by the gathering of global leaders to tackle climate change.

    Placeholder for loading
    TF-health-523788878.jpg

    The healthcare sector contributes over 4% of global greenhouse gas emissions. Recognising that the sector must do more to drive the sustainable transition, members of the Taskforce are committed to developing a collective roadmap to accelerate the delivery of a net zero, sustainable health system.

    In coordination with other SMI Taskforces, the Health Systems Taskforce will focus its attention on delivering action in the following three priority areas:

    1. Digital healthcare

    The group will identify opportunities to utilise digital innovation and technology to accelerate the shift to net zero across the sector. Areas of focus may include incentivising innovation and increasing regulatory harmonisation for digital technologies and AI across R&D, manufacturing and supply and healthcare delivery.

    2. Supply chains

    The group will work to accelerate the net zero transition across health systems supply chains. Areas of focus may include infrastructure, freight and logistics, the procurement of goods and services, and driving greater innovation and circularity across the supply chain.

    3. Patient care pathways

    The group will identify opportunities to deliver net zero, patient-centric care. Areas of focus may include increasing investment and incentives for the prevention of ill health, early detection and diagnosis, and optimising care to improve outcomes for patients, health systems, the environment and society at large.

    The Taskforce will also focus on the development of initiatives and shared commitments in the areas of:

    • The measurement of and metrics for the assessment of the environmental impact of Health Systems; and

    • Education and wider policy change

    The Taskforce can invite additional subject matter experts. The Taskforce will keep national and global policy and decision-makers updated on its activities, and will provide regular reports on progress in the lead up to COP27 in 2022.

    The Taskforce and its members will operate on a consensus basis. None of the content or outputs from the Taskforce will be related to or focused on specific products and they will not be promotional. Taskforce members will not share commercially sensitive or confidential information concerning their products or activities. All Taskforce members are committed to ensuring that the Taskforce and its activities will be conducted in a manner that complies with applicable laws in order to deliver on its mission to improve individual, societal and planetary health.

    Taskforce Members

    Pascal Soriot

    CEO, AstraZeneca

    Dr. Fiona Adshead

    Chair, Sustainable Healthcare Coalition

    Henrietta Fore

    Executive Director, UNICEF

    Lars Fruergaard Jørgensen

    CEO, Novo Nordisk

    Belén Garijo

    CEO, Merck

    Dr. Tedros Ghebreyesus

    Director General, World Health Organization

    André Hoffman

    Vice Chairman, Roche

    Paul Hudson

    CEO, Sanofi

    Prof. Ole Petter Ottersen

    President, Karolinska Institutet

    Lord David Prior

    Prior Chair, NHS England

    John Rim

    CEO, Samsung Biologics

    Prof. Francesco Svelto

    Rector, University of Pavia

    Dame Emma Walmsley

    CEO, GSK

    Decarbonisation of the global healthcare system is the priority for new Health Systems Taskforce launched at COP26

    With over four percent of greenhouse gases coming from the healthcare sector, it’s imperative that we take action and make healthcare more sustainable – for the health of people, society and the planet.

    The SMI Health Systems Taskforce has a key role to play, and I am honoured and excited to be working with other like-minded leaders to drive change. Together, we can harness the power of innovation and shape and advance policies that will accelerate the delivery of net zero healthcare.

    Pascal Soriot, Chief Executive Officer, AstraZeneca
    Placeholder for loading
    AZ_BoD_Pascal_Soriot.jpg

    Further information

    For roundtable and taskforce enquiries please contact, Jerome Fitzgerald, Chief Industry Officer, Sustainable Markets Initiative:

    Email: j.fitzgerald@sustainable-markets.org

    For media enquiries please contact Andrea Newman, Chief Marketing and Communications Officer, Sustainable Markets Initiative:

    Email: a.newman@sustainable-markets.org